Anxiety, Distress and Stress among Patients with Diabetes during COVID-19 Pandemic: A Systematic Review and Meta-Analysis

García‐Lara, Rubén A.; Gómez‐Urquiza, José Luis; Membrive‐Jiménez, María José; Velando‐Soriano, Almudena; Granados-Bolivar, Monserrat E.; Romero‐Béjar, José L.; Suleiman‐Martos, Nora

doi:10.3390/jpm12091412

Cited by 15 publications

(12 citation statements)

References 95 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, the COVID-19 pandemic may exacerbate the risk for depression among individuals with chronic illnesses ( Chen et al, 2020 ; Özdin and Bayrak Özdin, 2020 ; Luo Y. et al, 2020 ; Wang C. et al, 2020 ). According to a meta-analysis to assess the levels and prevalence of anxiety, distress, and stress in patients with diabetes during the COVID-19 pandemic, the prevalence of anxiety in type 2 diabetes patients was 20 and 36% in diabetes distress ( García-Lara et al, 2022 ), which were higher than those in the pre-pandemic period [18% ( Chaturvedi et al, 2019 ) and 29.4% ( Huynh et al, 2021 ), respectively]. Similarly, a study in China on 658 patients with breast cancer found that severe anxiety and depression during the COVID-19 pandemic were 8.9 and 9.3%, respectively.…”

Section: Discussionmentioning

confidence: 99%

Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea

Park

2023

Front. Psychol.

View full text Add to dashboard Cite

ObjectiveThe unprecedented coronavirus disease 2019 (COVID-19) outbreak has resulted in a global crisis that negatively impacted physical well-being and mental health. Our goal was to investigate the impact of the COVID-19 pandemic on health-related quality of life (HRQoL) and depressive symptoms in patients with chronic diseases and the general population in Korea.MethodsData from 8341 patients with chronic diseases and 12,395 general population aged ≥20 years who participated in the Korea National Health and Nutrition Examination Survey (2017–2020) were analyzed. Patients with hypertension, dyslipidemia, diabetes, cerebrovascular disease (stroke), heart disease (myocardial infarction or angina pectoris), or cancer were classified as patients with chronic diseases. The general population was defined as those not suffering from corresponding chronic diseases. A modified EuroQol-5 Dimensions (EQ-5D), with three levels (0: extreme problems; 0.5: some problems; 1: no problems) for each dimension in EQ-5D, was used to assess HRQoL. To analyze depressive symptoms among patients with chronic diseases and the general population, we used the Patient Health Questionnaire-9 (PHQ-9) and defined a PHQ-9 score ≥ 10 as having a depressive symptom. Multivariate linear and logistic regression analyses were used to analyze HRQoL and depressive symptoms before and during the COVID-19 pandemic.ResultsThe HRQoL level was significantly lower in patients with chronic diseases compared to the general population on all dimensions both before and during the COVID-19 pandemic (all value of p < 0.05). Patients with chronic diseases had significantly lower HRQoL levels associated with the anxiety/depression dimension during the COVID-19 pandemic than in the pre-pandemic period (0.940 ± 0.002 vs. 0.929 ± 0.004, value of p = 0.041). In addition, patients with chronic diseases were more likely to report depressive symptoms during the COVID-19 pandemic than in the pre-pandemic period (Odds ratio (OR): 1.755, 95% confidence interval (CI): 1.209–2.546, value of p = 0.003). However, this association was not observed in the general population (OR: 1.275, 95% CI: 0.933–1.742, value of p = 0.13).ConclusionThe COVID-19 pandemic affected the HRQoL and psychological health in patients with chronic diseases with higher anxiety/depression during the pandemic than in the pre-pandemic period. These results suggest that it is urgent to establish continuous management guidelines, including psychosocial management for high-risk groups, and to improve the existing healthcare system.

show abstract

Section: Discussionmentioning

confidence: 99%

Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea

Park

2023

Front. Psychol.

View full text Add to dashboard Cite

show abstract

“…These findings align with previous research, indicating that as individuals age, distress related to diabetes intensifies. 11 , 26 , 27 The correlation highlights the challenges older clients encounter in harmonising diabetes management with family tasks, emphasizing the need for targeted healthcare strategies and support to address their unique concerns. Chima et al argues that healthcare delivery system in Malawi should encompass specialized counselling, targeted education, and community outreach to support older patients living with diabetes.…”

Section: Discussionmentioning

confidence: 99%

Prevalence and Associated Factors of Psychological Distress Among Diabetic Patients at Thyolo District Hospital in Malawi: A Hospital-Based Cross-Sectional Study

Blangeti,

Chima,

Kamanga

et al. 2024

DMSO

View full text Add to dashboard Cite

Background Emotional distress experienced by individuals with diabetes represents a type of psychological strain specific to the challenges posed by diabetes. It mirrors the emotional reactions arising from coping with the demands of the illness and the essential care associated with diabetes. The study aimed to determine the prevalence and associated factors of psychological distress among diabetic patients at Thyolo District Hospital in Malawi. Objective To determine the prevalence and associated factors of psychological distress among diabetic patients at Thyolo District Hospital in Malawi. Methods The cross-sectional study involved 171 participants chosen using a simple random sampling technique at Thyolo District Hospital. The study was conducted from June 28 to July 27, 2023. The data were inputted into SPSS version 23.0, and descriptive statistics were employed for analysis. Cross-tabulation, utilizing Pearson chi-square, and correlation analysis were performed. The statistical significance level was established at P <0.05. Results Out of the 171 participants included in the study, 44 (25.7%) reported experiencing diabetic distress. According to levels of psychological distress, the study reports that 27 (15.8%) had mild depression, while 5 (2.9%) presented with moderate depression and 1 (0.6%) had extremely severe depression. As regards to levels of anxiety, 14 (8.2%) had mild anxiety, while 5 (2.9%) had moderate anxiety. In terms of stress levels, only one participant (0.6%) reported mild stress, and an equal proportion reported moderate stress. Additionally, age was identified as a significant factor associated with psychological distress, with a p-value of 0.001. Conclusion Approximately 33% of the diabetic patients involved in this study revealed psychological distress, and this condition showed a statistically significant association with age. Conducting routine assessments and implementing early control measures for the associated factors are crucial in mitigating both the prevalence and the impact of psychological distress among diabetic patients.

show abstract

“…Chronic disease increases the risk of the patient suffering an emotional and/or behavioral disorder, especially in times of social crisis such as that experienced with the COVID-19 pandemic [ 76 ]. This relationship has been demonstrated, with different levels of intensity and frequency, for the signs and symptoms of depression [ 77 ].…”

Section: Discussionmentioning

confidence: 99%

Prevalence of Depression and Related Factors among Patients with Chronic Disease during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

et al. 2022

Self Cite

View full text Add to dashboard Cite

The management of chronic diseases in the midst of the COVID-19 pandemic is especially challenging, and reducing potential psychological harm is essential. This review aims to determine the prevalence of depression during the COVID-19 pandemic in patients with chronic disease, and to characterize the impacts of related factors. A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The meta-analysis was performed using StatsDirect software. The review identified 33 articles with a total of 50,905 patients with chronic diseases. Four meta-analyses were performed to estimate the prevalence of depression. In diabetic patients, the prevalence ranged from 17% (95% CI = 7–31) (PHQ-9) to 33% (95% CI = 16–51) (PHQ-8); in obese patients, the prevalence was 48% (95% CI = 26–71); and in hypertensive patients, the prevalence was 18% (95% CI = 13–24). The factors significantly associated with depression were female sex, being single, deterioration in the clinical parameters of diabetes, a decrease in self-care behavior, reduced physical activity and sleep time and fear of contagion. The COVID-19 pandemic has significantly increased levels of depression among persons with chronic disease. Pandemics and other emergency events have a major impact on mental health, so early psychological interventions and health management policies are needed to reinforce chronic patients’ physical and mental health.

show abstract

Anxiety, Distress and Stress among Patients with Diabetes during COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Cited by 15 publications

References 95 publications

Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea

Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea

Prevalence and Associated Factors of Psychological Distress Among Diabetic Patients at Thyolo District Hospital in Malawi: A Hospital-Based Cross-Sectional Study

Prevalence of Depression and Related Factors among Patients with Chronic Disease during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About